INDSWFTLAB — IND Swift Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹28.48bn
- IN₹24.36bn
- IN₹6.49bn
India's Ind Swift Laboratories hits circuit breaker on nod to sell API business
India's Ind-Swift Labs to sell pharma ingredients ops for $198.5 mln
Brief: Ind Swift Laboratories Approves Slump Sale Of API Business To Synthimed Labs
Brief: Ind Swift Laboratories Approves Sale Of Property Of Co At Mumbai At Total Consideration Of 27.5 Million Rupees
Brief: India's Ind Swift Laboratories June-Quarter Consol Net PAT Falls
Brief: India's Ind Swift Laboratories March-Quarter Consol Net Loss After Tax Narrows
Brief: Ind Swift Laboratories Approved Sale Of Unit Halcyon Life Sciences To RN Chemicals & Pharmaceutical
Brief: India's Ind Swift Laboratories Ltd Dec-Quarter Consol Profit From Continuing Operations Rises
Brief: India's Ind Swift Laboratories Sept-Qtr Consol Net Pat Rises
Brief: Ind Swift Laboratories Says Arbitral Tribunal Has Dismissed Application Of PI Industries
Brief: IND Swift Laboratories Dec-Quarter Consol Net PAT Rises
Media: India's Ind-Swift Labs in talks with private equity cos to sell stake - Economic Times
Indian agro chemical maker PI Industries drops as IND Swift Lab deal falls through
Brief: PI Industries Says Business Transfer Agreement Dated July 30 Between Co, Ind Swift Laboratories Is Terminated
Brief: India's IND Swift Laboratories Says Sept-Quarter Consol Net PAT Rose
Brief: Ind Swift Laboratories June Qtr Consol Net PAT Rises
Brief: Ind Swift Laboratories March Qtr Net Loss After Tax Widens
Brief: India's IND Swift Laboratories Posts Dec-Quarter Consol Net PAT
Brief: Ind Swift Laboratories Posts Sept-Qtr Consol Net Profit